子宮頸がん治療薬の世界市場2015-2019...市場調査レポートについてご紹介

【英文タイトル】Global Cervical Cancer Market 2015-2019

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Disease overview
Understanding the disease
Risk factors
Signs and symptoms
Screening
Diagnosis
Staging
Treatment
Epidemiology

PART 06: Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 07: Market segmentation by application
Global prophylactic vaccines market
Global therapeutic drugs market

PART 08: Market segmentation by type of therapy
Global cervical cancer therapeutics market by type of therapy
Chemotherapy
Targeted therapy
HPV vaccines

PART 09: Geographical segmentation

PART 10: Key brand analysis
Comparative study between Gardasil, Gardasil 9, and Cervarix

PART 11: Pipeline portfolio

PART 12: Market drivers

PART 13: Impact of drivers

PART 14: Market challenges

PART 15: Impact of drivers and challenges

PART 16: Market trends

PART 17: Vendor landscape
Competitive scenario
Market analysis 2014
Other prominent vendors

PART 18: Key vendor analysis
GSK
F. Hoffmann-La Roche
Merck

PART 19: Appendix
List of abbreviations

PART 20: Explore Technavio

[List of Exhibits]

Exhibit 01: Risk factors for cervical cancer
Exhibit 02: Screening tests for cervical cancer
Exhibit 03: Diagnostic tests for cervical cancer
Exhibit 04: FIGO staging for cervical cancer
Exhibit 05: Management of cervical cancer
Exhibit 06: Chemotherapy for treatment of cervical cancer
Exhibit 07: Cervical cancer treatment algorithm
Exhibit 08: Countries with highest cervical cancer rates
Exhibit 09: Cervical cancer deaths by age group in the US 2008-2012
Exhibit 10: Age-specific incidence rates of cervical cancer in the US by race 2008-2012
Exhibit 11: Age-specific mortality rates of cervical cancer of women in the US by race 2008-2012
Exhibit 12: Mortality rates of cervical cancer of women in the US by race 2008-2012
Exhibit 13: Average number of cervical cancer deaths in EU 2010-2012
Exhibit 14: Cervical cancer incidence and mortality rates in EU 2007-2011
Exhibit 15: Global cervical cancer therapeutics market 2014-2019 ($ billions)
Exhibit 16: Global cervical cancer therapeutics market segmentation by application
Exhibit 17: Global prophylactic vaccines market 2014-2019 ($ millions)
Exhibit 18: Global therapeutic drugs market 2014-2019 ($ millions)
Exhibit 19: Segmentation of global cervical cancer therapeutics market 2014
Exhibit 20: Global cervical cancer therapeutics market by type of therapy
Exhibit 21: Segmentation of global cervical cancer therapeutics market by region 2014
Exhibit 22: Global cervical cancer vaccines market: Comparison of major brands
Exhibit 23: Gardasil, Gardasil 9, and Cervarix: A comparative study
Exhibit 24: Key late-stage HPV vaccines for cervical cancer
Exhibit 25: Drivers of global cervical cancer therapeutics market
Exhibit 26: Impact of drivers
Exhibit 27: Challenges of global cervical cancer therapeutics market
Exhibit 28: Impact of drivers and challenges
Exhibit 29: Trends of global cervical cancer therapeutics market
Exhibit 30: Gardasil: Global revenue and growth rate 2011-2014
Exhibit 31: Merck: Key takeaways
Exhibit 32: Cervarix: Global revenue and growth rate 2012-2014
Exhibit 33: GSK: Key takeaways
Exhibit 34: F. Hoffman-La Roche: Key takeaways


【レポート販売概要】

■ タイトル:子宮頸がん治療薬の世界市場2015-2019
■ 英文:Global Cervical Cancer Market 2015-2019
■ 発行日:2015年9月9日
■ 調査会社:Technavio
■ 商品コード:IRTNTR7066
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。